A company car <a href="http://nonbaohiemchinhhang.com/stmap_cc130.html?divalproex.trihexyphenidyl.cialis">dil-med.pl</a>  It works by attaching Herceptin to a drug called DM1,developed by ImmunoGen, which interferes with cancercell growth. ImmunoGen will receive a $5 million milestonepayment from Roche following the Japanese approval.